Lopinavir Enrolling by Invitation Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Enrolling by Invitation | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| https://clinicaltrials.gov/ct2/show/ | Interferon Beta 1a in Hospitalized COVID-19 Patients | |
| https://clinicaltrials.gov/ct2/show/ | Umifenovir in Hospitalized COVID-19 Patients |